1 / 35


Immunodeficiency. Primary (congenital) immunodeficiencies: inherited disorders that arise from a genetic defect Secondary immunodeficiencies: arise from extrinsic causes Malnutrition Irradiation Infections Immunosuppressive therapy. How Immunodeficiency Diseases Present.

Download Presentation


An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.


Presentation Transcript

  1. Immunodeficiency • Primary (congenital) immunodeficiencies: inherited disorders that arise from a genetic defect • Secondary immunodeficiencies: arise from extrinsic causes • Malnutrition • Irradiation • Infections • Immunosuppressive therapy

  2. How Immunodeficiency Diseases Present • Recurrent or chronic pyogenic (pus-forming) infections • These indicate defects in • Antibodies and/or B cells • Complement components • Phagocytes • Common agents are encapsulated bacteria • Streptococcus pneumoniae • Neisseria meningitidis • Staphylococcus aureus • Haemophilus influenzae • Common clinical manifestations • Bacterial pneumonia • Otitis media • Sinusitis • Meningitis • Osteomyelitis • Infections with gram-negative enterics

  3. How Immunodeficiency Diseases Present • Recurrent or chronic opportunistic infections • These indicate defects in T cells • Common agents • Viruses, e.g. rotavirus, HIV • Fungi, e.g. Candida, Pneumocystis jiroveci • Protozoans, e.g. Toxoplasma • Atypical mycobacteria • Leads to combined deficiency of CMI and humoral immunity • Cancer • Usually indicates T cell deficiency • EBV, Kaposi sarcoma

  4. How Immunodeficiency Diseases Present • Diseases that present as antibody deficiencies • X-linked agammaglobulinemia • Selective IgA and IgG subclass deficiencies • Hyper IgM syndrome • Common variable immunodeficiency • Transient hypogammaglobulinemia of infancy • Diseases that present as T cell or combined deficiencies • SCID • DiGeorge syndrome • Hereditary ataxia-telangiectasia • Wiskott-Aldrich syndrome • Phagocytic cell deficiencies • Chronic granulomatous disease • Leukocyte adhesion deficiency • Chédiak-Higashi disease • Hyper IgE (Job) syndrome • Complement deficiencies • Hereditary angioedema • Paroxysmal nocturnal hemoglobinuria • Component deficiencies

  5. X-linked Infantile (Bruton’s) Agammaglobulinemia (XLA) • Males only; rare • btk gene defect • First presents at 5-6 months of age • Repeated pyogenic infections that don’t respond to antibiotics, Giardia lamblia • Passive immunity from mom has dissipated • Near absence of all antibodies: no response to vaccines, no isohemagglutinins • Scant lymphoid tissue • By 20-30 y, bronchiectasis may cause death • T cells OK, so live vaccines OK Antibody deficiencies

  6. Selective IgA Deficiency • Common in Caucasians • Serum IgA <50 mg/ml • Sinopulmonary infections, celiac disease, immune complex disease • May be asymptomatic • May progress to CVID • Persons with IgA deficiency may possess IgE directed toward IgA • Wash those RBCs before transfusion! Antibody deficiencies

  7. Selective IgG Subclass Deficiency • Total serum IgG may be normal • IgG3 deficiency most common in adults • IgG2 deficiency most common in children • May lead to increased bacterial infections, or have no problems Antibody deficiencies

  8. Hyper-IgM Syndrome • Low levels of IgG and IgA with increased levels of IgM • IgM autoantibodies to neutrophils, platelets, tissue antigens • B cells can’t class-switch • X-linked (70%) • T cell defect in CD40L • No T cell activation of macrophages • Defective CMI  P. jiroveci • Autosomal recessive (30%) • Defect in CD40 gene in B cells and APCs • Defect in activation-induced cytidine deaminase (AID) gene in the B cell Antibody deficiencies

  9. Common Variable Immunodeficiency (CVID) • Common variable hypogammaglobulinemia • Males and females • Usual onset 15-35 y • May follow EBV infection • Associated with selective IgA deficiency • Low serum IgG and IgA, low or normal IgM, low or normal B cell count • Mothers cannot confer passive protection on infants • Marked by • Pyogenic bacterial infections • Autoimmune diseases, especially pernicious anemia • Giardiasis • Malignant neoplasms • Variable defects Antibody deficiencies

  10. Transient Hypogammaglobulinemia of Infancy • Males and females • Presents at 5-6 months • May persist through 2-3 years of age • IgG absent, IgM and IgA normal • B cells are normal • No class switching to IgG due to TH defect • TH defect precludes live viral vaccines! • Normal numbers of B cells in blood, unlike XLA Antibody deficiencies

  11. Treatments for Antibody Deficiencies • Broad-spectrum antibiotics • Intravenous immune globulin – contains mostly IgG • Do not treat selective IgA deficiency with IVIG • Patients may possess IgE specific for IgA • Administration of IgA may cause anaphylaxis • If your patient is both IgG and IgA deficient, correct the IgG deficiency with an IVIG prep that contains no IgA – Gammagard S/D • Treat IgA deficiency with antibiotics Antibody deficiencies

  12. Severe Combined Immunodeficiency (SCID) • Heterogeneous disorder with defects in CMI and antibody • Patients susceptible to all types of infections – rotavirus, CMV, candidiasis, Pneumocystis jiroveci • Diarrhea and pneumonia • Vaccination with live microbes is lethal • Symptoms occur earlier than in XLA • Fatal before age 1 year if untreated • Treat with bone marrow transplant • There are three phenotypes: T–B+, T–B–, T+B+ T/combined

  13. Severe Combined Immunodeficiency (SCID) • T–B+ subgroup • X-linked • Defect in the g chain of the receptor for IL-2, 4, 7, 9, and 15 • Recessive mutation – heterozygous females are phenotypically normal carriers Failure to activate transcription of specific genes T/combined

  14. Severe Combined Immunodeficiency (SCID) • T–B+ subgroup • Autosomal recessive • Defect in the  chain of IL-7 or in the JAK3 tyrosine kinase • JAK3 tyrosine kinase is responsible for transmitting signals from the  chain of the receptors for IL-2, 4, 7, 9, 15 T/combined

  15. SCID continued • T-B- subgroup • Defects in adenosine deaminase (ADA) • Accumulation of intracellular S-adenosylhomocysteine and dATP • T and B lymphocytes are particularly susceptible • Lack compensatory 5’-nucleotidase • Treat with gene therapy, continuous enzyme supplementation, or bone marrow transplant • RAG-1 and RAG-2 deficiencies • Stops B and T maturation at pre-B and pre-T stages T/combined

  16. SCID continued • T+B+ subgroup • Bare lymphocyte syndrome • Cells lack MHC class II • No collaboration between APCs and TH cells • Class I MHC/TAP deficiency • Defect in TAP transporter gene • No loading of processed peptide into MHC class I groove • Empty MHC class I molecule is unstable and not expressed on APC surface T/combined

  17. Congenital Thymic Aplasia (DiGeorge Syndrome) • Thymus (and parathyroid) fails to develop from 3rd & 4th pharyngeal pouches • Few or no T cells • Hypocalcemic tetany 24 h due to hypoparathyroidism • Congenital defects in heart and kidneys • Hypertelorism, low-set ears, shortened philtrum T/combined

  18. DiGeorge Syndrome continued • B cells present, but no IgG production • No live vaccines! • Not hereditary, deletion in chromosome 22 • Immunodeficiency treated by bone marrow transplant • BMT may not be necessary • T cell function may be normal by age 5 years • Nude mouse model T/combined

  19. Hereditary Ataxia-Telangiectasia • Neurologic, immunologic, endocrine, hepatic and cutaneous abnormalities • Defective DNA repair gene • DNA breaks in chromosomes 7 and 14 encoding TCR and heavy chain go unrepaired • Presents at 18 months: wobbly gait (ataxia) • Telangiectasia (dilated capillaries) appear on skin and in eyes by 6 y • Severe sinus and lung infections • Autoimmune disorders and cancer T/combined

  20. Wiskott-Aldrich Syndrome • X-linked • wasp gene defect coding for cytoskeletal protein • Decreased signal transduction through adapter proteins • Accelerates Fas-mediated lymphocyte apoptosis • Presents at ~20 months • Thrombocytopenia leading to bleeding disorder • Small platelets • Low IgM, normal IgG, high IgA and IgE • Eczema • Pyogenic and opportunistic infections • Cannot respond to polysaccharide vaccines • Tx: antibiotics, anti-virals, bone marrow transplant • Life expectancy 3 y without antibiotics, 30 y with antibiotics but without immune reconstitution • Death due to lymphoid malignancy T/combined

  21. Chronic Granulomatous Disease (CGD) • Phagocytes lack functional NADPH oxidase  no superoxide, no peroxide, leads to intracellular survival of fungi and bacteria • Usual onset early childhood • 2/3 of cases are X-linked • Signs and symptoms • Repeated infections by catalase positive bacteria and fungi • Staphylococcus, Serratia, Burkholderia, Aspergillus, Candida • Granulomas • Pneumonia • Lymphadenitis • Abscesses in skin, liver and viscera • Tx • Antimicrobials, aggressive immunization • IFN • NBT test for diagnosis • CGD phagocytes fail to reduce NBT to formazan • In CGD phagocytes, there’s no color change from yellow to purple Normal CGD Phagocyte defects

  22. Leukocyte Adhesion Deficiency • LAD I • Defective CD18 (an integrin b chain) common to LFA-1 and CR3 • No extravasation • Leukocytosis • No pus formation • No phagocytosis of microbes opsonized by complement • Severe infections spread rapidly, especially in mouth and GI tract • Treat with bone marrow transplant CD15 • LAD II • – Impaired fucose metabolism, e.g. sialyl Lewis X/CD15 Phagocyte defects

  23. Chédiak-Higashi Disease • Defective granules in lysosomes and melanosomes • No intracellular killing • Signs and symptoms • Recurrent Staphylococcus, Streptococcus and Pseudomonas infections of skin, lungs, respiratory tract • Lymphoma-like infiltration of organs by leukocytes with giant cytoplasmic granules • Hypopigmentation because of faulty melanosomes • NK cell activity depressed • Tx: antibiotics, some BMT • Poor prognosis Phagocyte defects

  24. Job’s Syndrome (Hyper IgE Syndrome) • Immunologic features • Recurrent boils and cold staphylococcal abscesses • IgE and chronic eczema • Recurrent cystic lung disease with S. aureus and C. albicans • Mucocutaneous candidiasis • Otitis media • Eosinophilia • Non-immunologic features (not always present) • Bone fractures, other skeletal abnormalities • Coarse facial features, e.g. prominent brow • Joint hyperextensibility • Retained primary dentition • Causative effects variable • Tx: antibiotics and anti-fungals • Tx for eczema: corticosteroids, tacrolimus as last resort Phagocyte defects

  25. Hereditary Angioedema (HAE) • Deficiency in C1 esterase inhibitor allows C1qr2s2 and plasmin to function unregulated • Type I (85%) – low levels of normal C1INH • Type II (15%) – normal or high levels of dysfunctional C1INH • Inherited or spontaneous mutations (acquired AE) • Unchecked activation of classical pathway consumes C4 and C2 • Low levels of C4 are diagnostic • Signs and symptoms • Edema caused by C2 product from plasmin cleavage • Local edema of hands, face, arms, legs, genitals, buttocks • Edema of stomach, intestines, bladder causes abdominal pain, constipation or diarrhea, cramps, vomiting • Laryngeal edema can lead to suffocation • Edema may be preceded by tingling and erythema • Edema caused by stress or trauma, e.g. dental procedure Complement defects

  26. Hereditary Angioedema (HAE) • Prophylaxis before dental or surgical procedures • Fresh frozen plasma to replace C1INH • Danazol to increase C4 • Treatment of on-going attack • Maintain airway • Narcotics for abdominal pain • IV fluids for hemodynamic stability Complement defects

  27. Paroxysmal Nocturnal Hemoglobinuria (PNH) • Stem cell defect in GPI anchors of complement regulators that protect human cells • Decay-accelerating factor (DAF) • Homologous restriction factor (HRF) • CD59 • Dark urine due to RBC lysis • Triad of symptoms • Anemia due to RBC lysis • Pancytopenia due to lysis of RBCs, WBCs, and platelets • Thrombosis in large vessels of liver, abdomen, brain, dermis • Thrombosis usual cause of death in PNH patients • Budd-Chiari syndrome – severe abdominal pain, enlarging liver, ascites • Additional signs and symptoms • Weakness, dyspnea, pallor, splenomegaly, iron deficiency, bleeding disorders, renal failure, severe headaches and eye pain (thrombotic vascular occlusion), chronic infections Complement defects

  28. Paroxysmal Nocturnal Hemoglobinuria (PNH) • Median survival 10 years • Variable age at onset • Dx • Flow cytometry to detect DAF and CD59 on peripheral blood cells • Sugar water test • Reduce salt concentration by adding isotonic sucrose • This causes lysis of PNH RBCs • Ham test • Acidify human serum to pH 6.2 • Add RBCs from PNH patient • RBCs will lyse if GPI-deficient • Tx • For hemolysis: prednisone or eculizumab (Mab to C5) • For anemia: iron supplements, packed RBCs, erythropoietin • For thrombosis: heparin for emergencies, then maintain patient on Coumadin anticoagulant • Stem cell transplant for aplastic anemia or leukemia Complement defects

  29. Complement Component Deficiencies • Deficiency in C5-C8 • Increased incidence of Neisseria infections • Vaccination with MCV4 or MPSV4 helps prevent infections • Deficiency in C3, Factor H, Factor I • Recurrent pyogenic bacterial infections • Vaccinate against Neisseria meningitidis and Streptococcus pneumoniae • Deficiency in C1, C2, C4 • Immune complex disease • SLE • Diagnosis of component deficiencies by CH50 assay • Perform dilution series of patient serum • Add serum dilutions to constant amount of sheep red blood cells coated with IgG • The complement titer is the reciprocal of the highest serum dilution to lyse 50% of the RBCs Complement defects

  30. Secondary Immunodeficiencies • Result from extrinsic causes • Poor nutrition is the leading cause world-wide • Cancer therapy, drugs to prevent graft rejection • Inflammatory bowel disease, skin burns – loss of antibodies • Surgical splenectomy • Infections of leukocytes Secondary immunodeficiencies

  31. Secondary Immunodeficiencies • Acquired immunodeficiency syndrome (AIDS) • Caused by human immunodeficiency virus (HIV) • Transmission • Sexual contact • Transfer of blood products • Contaminated needles • Mother to child during pregnancy, birth, or breast-feeding • HIV infects all cells expressing CD4 • TH cells • Monocytes/macrophages • Dendritic cells • Langerhans cells • Microglial cells Secondary immunodeficiencies

  32. Secondary Immunodeficiencies - AIDS • HIV also requires chemokine receptor as co-receptor • M-tropic viruses use CCR5 • Prefer macrophage host cells • M-tropism early in disease • Persons with mutant CCR5 are HIV-resistant • T-tropic viruses use CXCR4 • Prefer TH host cells • May be evolution from M-tropic to T-tropic as gp120 mutates • Early signs and symptoms • Fevers caused by IL-1 production • Night sweats • Diarrhea • Cachexia due to TNF release Secondary immunodeficiencies

  33. Secondary Immunodeficiencies - AIDS • Later • Profound loss of CD4+ TH cells • <200 TH cells/l • TH:Tc reverses to 1:2 • Loss of humoral and cell-mediated immunity • Recurrent/opportunistic infections • Varicella-zoster – shingles • Herpes simplex – genital and anal lesions • Candida albicans – oral thrush • Cryptosporidium, Campylobacter, Salmonella, microsporidia – diarrhea • Pneumocystis, Mycobacterium, fungi – pneumonia • Toxoplasma – brain abscesses • CMV – esophageal ulceration, chorioretinitis, CNS • JC virus – progressive multifocal leukoencephalopathy • Lymphoma (EBV), Kaposi sarcoma (HHV-8), dementia, paralysis Secondary immunodeficiencies

  34. Kaposi’s sarcoma lesions Pneumocystis jiroveci pneumonia Cryptosporidium CT Cerebral toxoplasmosis Small bowel Secondary immunodeficiencies

  35. Secondary Immunodeficiencies - AIDS • No vaccine, no cure • Tx: highly active antiretroviral therapy (HAART) • Combination therapy from these categories • Nucleoside reverse transcriptase inhibitors • Non-nucleoside reverse transcriptase inhibitors • Protease inhibitors • Inhibitors of viral entry – chemokine receptor antagonists, inhibitors of viral-cell membrane fusion • Integrase inhibitors under development – prevent integration of proviral DNA into host cell genome Secondary immunodeficiencies

More Related